Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2015

May 13, 2015

34129_dirs_2015-05-13_a9cdc7a7-019c-432e-bcee-16c7d7526d03.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2015-05-11

Reporting Person: HURWITZ EDWARD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-05-11 Common Stock J 18074 Acquired 18074 Direct

Footnotes

F1: Pro rata distribution from Alta BioPharma Management III, LLC., of which the reporting person is a non-managing director.